JAGX
Jaguar Animal Health IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.50M
P/E Ratio
—
EPS
$-803.95
Beta
0.03
52W High
$171.50
52W Low
$2.53
50-Day MA
$10.36
200-Day MA
$40.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
200.00
PEG Ratio
-0.02
About Jaguar Animal Health Inc
Jaguar Health, Inc., a commercial-stage pharmaceutical company, focuses on developing prescription drugs for people and animals with gastrointestinal upset, specifically chronic debilitating diarrhea. The company is headquartered in San Francisco, California.
Fundamentals
| Revenue (TTM) | $11.51M |
| Gross Profit (TTM) | $7.74M |
| EBITDA | $-43.20M |
| Operating Margin | -632.00% |
| Return on Equity | -411.60% |
| Return on Assets | -61.50% |
| Revenue/Share (TTM) | $172.73 |
| Book Value | $-99.20 |
| Price-to-Book | 1.62 |
| Price-to-Sales (TTM) | 0.14 |
| EV/Revenue | 4.163 |
| EV/EBITDA | -0.63 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -7.80% |
| Shares Outstanding | 513,940 |
| Float | 352,760 |
| % Insiders | 6.38% |
| % Institutions | 1.22% |
Historical Volatility
HV 10-Day
167.33%
HV 20-Day
136.90%
HV 30-Day
130.27%
HV 60-Day
142.31%
HV Rank
—
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/25/2026